Three KU Research Achievements Selected for ‘2025 Top 100 Excellent National R&D Outcomes’

Achievements in Information, Life Sciences, and Convergence Fields Highlight Korea’s Research Competitiveness

(From left) Prof. Heui-Seok Lim (School of Computer Science), Prof. Kyungmi Lee (Department of Biomedical Sciences), Prof. Sung-Kyu Seo (Department of Electronic and Information Engineering)

Korea University (President Dongwon Kim) announced that three of its research achievements have been selected for the Ministry of Science and ICT’s “2025 Top 100 Excellent National R&D Outcomes” on December 23, 2025. The selected researchers are Prof. Heui-Seok Lim (School of Computer Science), Prof. Kyungmi Lee (Department of Biomedical Sciences), and Prof. Sung-Kyu Seo (Department of Electronic and Information Engineering).

The Top 100 Excellent National R&D Outcomes program has been implemented annually since 2006 to discover and promote outstanding research accomplishments generated through national R&D programs. This year, 100 finalists were selected following expert evaluations and public verification from among 970 nominees recommended by ministries and government agencies.

Korea University’s selections span the fields of information & electronics, life sciences & marine science, and convergence research, demonstrating the university’s strong capabilities from fundamental science to advanced technology and commercialization-driven convergence research.

Prof. Heui-Seok Lim was selected in the information & electronics category for developing a Korean language-optimized generative and retrieval AI model. His research significantly enhanced the accuracy and applicability of Korean-language AI technologies by overcoming limitations of conventional general-purpose models.

Prof. Kyungmi Lee was selected in the life sciences & marine category for identifying the role of CD244—an immune regulatory factor in tumor-associated macrophages—in refractory recurrent cancers and presenting new therapeutic potential based on this mechanism. Her work provides a novel immuno-oncology approach by elucidating immune regulation within the tumor microenvironment and overcoming limitations of existing treatment modalities.

Prof. Sung-Kyu Seo was selected in the convergence field for the development and commercialization of a digital inline holography-based personalized immune diagnostics system, in collaboration with faculty startup MetaImmuneTech Inc. The research integrates AI and biophotonics technologies into in vitro diagnostic devices, demonstrating the feasibility of personalized immune function monitoring.

Selected research outcomes receive an official certificate and plaque from the Minister of Science and ICT, and are eligible for follow-up support including assistance for advancing technology readiness levels, commercialization, and subsequent research.

Link : https://www.korea.ac.kr/ko/552/subview.do?enc=Zm5jdDF8QEB8JTJGa3VzdG9yeSUyRmtvJTJGYXJ0Y2xWaWV3LmRvJTNGYXJ0Y2xTZXElM0QyODIwOCUyNnNpdGVJZCUzRGtvJTI2cGFnZSUzRDElMjZmaW5kVHlwZSUzRCUyNmZpbmRXb3JkJTNEJTI2ZmluZENsU2VxJTNEJTI2cmdzQmduZGVTdHIlM0QlMjZyZ3NFbmRkZVN0ciUzRCUyNg%3D%3D

Cellytics NK – Rapid Immunity Check for All

Cellytics NK is an innovative digital healthcare tool that checks your immune system using advanced technology, Lens-free Imaging Technology. It looks at a special type of immune cell called Natural Killer cells quickly and precisely. These cells are important for your body’s defense. With just a small blood sample, CellyticsTM NK can tell you about your immunity without you having to go to a specific place. The results are given in a simple report that’s easy to understand. This product is a convenient way for anyone to check their immunity in the age of digital health.

 

Link : https://www.ces.tech/ces-innovation-awards/2024/cellyticstm-nk-rapid-immunity-check-for-all/?utm_source=chatgpt.com

Seoul Metropolitan Government hosts the largest-ever ‘Seoul Pavilion’ at CES 2024 with 18 innovation awards recipients

  • Seoul Pavilion at CES 2024: Largest ever, featuring 81 startups across healthcare, AI, mobility, manufacturing, ESG, and quantum tech.

  • Awards: 18 Seoul startups won CES Innovation Awards, including TopTable and LordSystem winning Best of Innovation (top 1%).

  • Mayor Oh Se-hoon: Attended opening, encouraged startups, met award winners, and pledged support to remove regulatory barriers.

  • Partners: 13 institutes (universities, Seoul BioHub, AI Hub, etc.) co-hosted the pavilion.

  • Goal: Expand Seoul’s global smart city competitiveness and help local startups enter international markets.

News Link : https://us.aving.net/news/articleView.html?idxno=50598&utm_source=chatgpt.com

Real-time immune monitoring of immunocompromised patients via lens-free shadow image analysis of natural killer cells

Highlights

  • Cellytics NK with Lens-Free Shadow Imaging enables rapid, accurate, cost-effective real-time assessment of NK cell activity.
  • Novel image-derived biomarkers (PPD, WSM-SD, CSP) and an Innate Immunity Index (I³) distinguish healthy from immunocompromised patients.
  • CSP and I³ show superior prognostic power, with CSP reaching diagnostic accuracy marked by an AUC above 0.95.
  • CSP and I³ outperform conventional hematological markers, including CD107a expression and interferon-γ release, in immune function assessment.
  • Successful commercialization of Cellytics NK highlights its clinical utility and transformative impact in real-world immune monitoring.

News Link : https://www.sciencedirect.com/science/article/abs/pii/S0925400525014224